11月21日,以“智领健康未来”为主题的2025华夏大健康产业发展暨康复服务大会在北京召开。作为连续四届引领行业风向的标杆盛会,科技与创新始终是贯穿全程的灵魂主线。 在圆桌会议上,荃信生物董事会秘书胡衍保在一场行业交流活动中分享了公司的发展历程与战略布局。作为一家专注于自身免疫及过敏性疾病领域的创新药企,胡衍保表示,荃信生物凭借扎实的研发实力与前瞻性布局,正加速推动自研创新药走向国际。 胡衍保...
Source Link11月21日,以“智领健康未来”为主题的2025华夏大健康产业发展暨康复服务大会在北京召开。作为连续四届引领行业风向的标杆盛会,科技与创新始终是贯穿全程的灵魂主线。 在圆桌会议上,荃信生物董事会秘书胡衍保在一场行业交流活动中分享了公司的发展历程与战略布局。作为一家专注于自身免疫及过敏性疾病领域的创新药企,胡衍保表示,荃信生物凭借扎实的研发实力与前瞻性布局,正加速推动自研创新药走向国际。 胡衍保...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.